CNBX Pharmaceuticals (CNBX) Stock Price, News & Analysis

Company Overview

CNBX Pharmaceuticals Corp. is a biotechnology company focused on the research and development of cannabinoid-based medical treatments. The company has investigated the potential use of cannabis-derived compounds in oncology and other therapeutic applications.

Its activities have included laboratory research, development of cannabinoid formulations, and evaluation of cannabis compounds for potential effects on cancer cells. CNBX has also pursued technologies intended to support the screening and analysis of medical cannabis and cannabinoid products.

The company has been associated with research and development operations in Israel. Publicly available information about its current product portfolio, commercial operations, and leadership is limited, and the company’s programs may be subject to ongoing development and regulatory requirements.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0007
• Volume: 50.68 million shs
• Average Volume: 24.33 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CNBX
• CIK: 1343009
• Web: cnbxpharma.com
• Phone: (877) 424-2429
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A